Vimarsana
Biggest News Aggregation in the World

Page 5 - Crispr Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crispr Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crispr Technology Today - Breaking & Trending Today

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics - Vimarsana News

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

These companies are in the early days of their growth stories.

Source: yahoo.com
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge - Vimarsana News

These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge

These risky stocks can deliver big returns for investors.

Source: yahoo.com
What are five new breakthroughs for cancer and Alzheimer's that will be accessible in India? | Health and Wellness News - Vimarsana News

What are five new breakthroughs for cancer and Alzheimer's that will be accessible in India? | Health and Wellness News

Wider availability of cheaper CAR-T cell therapy or engineering immune cells to treat blood cancer and a government HPV vaccination programme will be among the key breakthroughs

'Remarkable' gene-editing treatment for sickle cell disease is approved by FDA - Vimarsana News

'Remarkable' gene-editing treatment for sickle cell disease is approved by FDA

The FDA has approved the world’s first gene-edited treatment for symptoms of sickle cell disease. Experts weigh in on the potential benefits and limitations.

Source: yahoo.com
FDA approves first use of CRISPR gene editing to treat sickle cell disease - Vimarsana News

FDA approves first use of CRISPR gene editing to treat sickle cell disease

The Food and Drug Administration (FDA) on Friday approved a new therapy for treating sickle cell disease, marking the first instance of CRISPR gene editing receiving approval from federal regulators. The FDA approved on Friday two new treatments for sickle cell disease (SCD): Casgevy and Lyfgenia. Casgevy, also known as exa-cel, is developed through a…

Source: yahoo.com